MCKESSON CORP MCK

Latest FY: 2026 Healthcare Medical Distribution
Market Price $868.89
Market Cap $103.07B
P/E Ratio 22.64
Quick Peer Compare (Healthcare):
Revenue (FY 2026) ↑12.4% YoY
$403.43B
3-Yr CAGR: 13.4%
Net Income ↑44.5% YoY
$4.76B
Net Margin: 1.2%
Free Cash Flow ↑3.1% YoY
$5.72B
FCF Yield: 5.55%
EPS (Diluted) ↑49.2% YoY
$38.38
Basic: $38.55
Return on Equity Efficiency
N/A
ROA: 5.8%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (MCK)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $198,533.0M $11,271.0M $5,070.0M $22.73 $4,744.0M $4,340.0M
FY 2018 $208,357.0M +4.9% $11,184.0M $67.0M -98.7% $0.32 -98.6% $4,345.0M $3,940.0M -9.2%
FY 2019 $214,319.0M +2.9% $11,754.0M $34.0M -49.3% $0.17 -46.9% $4,036.0M $3,610.0M -8.4%
FY 2020 $231,051.0M +7.8% $12,023.0M $900.0M +2,547.1% $4.95 +2,811.8% $4,374.0M $4,012.0M +11.1%
FY 2021 $238,228.0M +3.1% $12,148.0M $-4,539.0M -604.3% $-28.26 -670.9% $4,542.0M $4,091.0M +2.0%
FY 2022 $263,966.0M +10.8% $13,130.0M $1,114.0M +124.5% $7.23 +125.6% $4,434.0M $4,046.0M -1.1%
FY 2023 $276,711.0M +4.8% $12,358.0M $3,560.0M +219.6% $25.03 +246.2% $5,159.0M $4,769.0M +17.9%
FY 2024 $308,951.0M +11.7% $12,828.0M $3,002.0M -15.7% $22.39 -10.5% $4,314.0M $3,883.0M -18.6%
FY 2025 $359,051.0M +16.2% $13,323.0M $3,295.0M +9.8% $25.72 +14.9% $6,085.0M $5,548.0M +42.9%
FY 2026 $403,430.0M +12.4% $14,550.0M $4,762.0M +44.5% $38.38 +49.2% $6,155.0M $5,719.0M +3.1%
$

Valuation

Market Price $868.89
Market Cap $103.07B
Enterprise Value $105.62B
P/E Ratio 22.64
P/B Ratio N/A
FCF Yield 5.55%
Dividend Yield 0.36%
Shares Outstanding 120,204,100
%

Profitability & Margins

Gross Margin 3.61%
Operating Margin 1.54%
Net Margin 1.18%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) 5.78%
Asset Turnover 4.90x
Revenue 3-Yr CAGR 13.39%
🛡️

Financial Health & Liquidity

Current Ratio 0.19
Cash Ratio 0.72
Debt / Equity -3.005
Debt / Assets 0.079
Cash & Equivalents $3.98B
Total Debt $6.53B
Book Value / Share $-18.07
💧

Cash Flow Efficiency

Operating Cash Flow $6.16B
Capital Expenditures (CapEx) $436.00M
Free Cash Flow $5.72B
OCF / Revenue 1.53%
FCF / Revenue 1.42%
FCF 3-Yr CAGR 6.24%
🏷️

Per Share Metrics

EPS (Diluted) $38.38
EPS (Basic) $38.55
Dividends / Share $3.17
Book Value / Share $-18.07
EPS YoY Growth 49.22%
🏛️

Balance Sheet (FY 2026)

Total Assets $82.32B
Total Liabilities $82.32B
Stockholders' Equity -$2.17B
Current Assets $1.04B
Current Liabilities $5.49B